How much do probiotics actually reduce the risk of antibiotic-associated diarrhea?
Probiotics cut the risk of antibiotic-associated diarrhea roughly in half. A large Cochrane review of 33 trials in children found that probiotics reduced the incidence of AAD from 19% in the control group to 8% in the probiotic group — a relative risk reduction of 55% [3]. This means that for every 9 children treated with probiotics, one case of diarrhea is prevented. The benefit was even stronger with high-dose probiotics (≥5 billion CFUs per day), where the number needed to treat dropped to 6 [3].
In adults, a 2024 systematic review of outpatient studies reported relative risk reductions ranging from 30% to 60% [2]. However, the evidence in adults is based on fewer studies and is less consistent. A 2022 trial in children using a specific multispecies probiotic found no effect on AAD when using the strictest definition (3 or more loose stools per day), but it did reduce overall diarrhea risk by 35% [1]. This highlights that the definition of diarrhea matters — probiotics may be more effective at preventing milder cases.
Which probiotic strains and doses are most effective?
High-dose probiotics (≥5 billion CFUs per day) are more effective than lower doses. The Cochrane review found that high-dose probiotics reduced AAD risk by 63% (from 23% to 8%), while low-dose probiotics showed a smaller, non-significant reduction [3]. The most studied strains with proven benefit are Lactobacillus rhamnosus and Saccharomyces boulardii [5]. Multistrain products may also work, but results vary. For example, one trial using an 8-strain probiotic (including Bifidobacterium and Lactobacillus species) did not reduce AAD by the strictest definition, though it did lower overall diarrhea [1].
A 2023 overview of 20 systematic reviews concluded that high-dose probiotics (5-40 billion CFUs per day) have a significant preventive effect, but the evidence is strongest for L. rhamnosus and S. boulardii [5]. Other strains lack sufficient data. Importantly, probiotics are generally safe — no serious adverse events were attributed to probiotics in the Cochrane review, though minor side effects like gas or bloating can occur [3].
Who should consider taking probiotics with antibiotics, and what are the caveats?
Children on broad-spectrum antibiotics are the best-studied group. The Cochrane review included 6,352 children and found a clear benefit [3]. However, a 2022 trial in 350 children found no effect on the strictest definition of AAD, suggesting that not all probiotics work equally [1]. For adults, the evidence is promising but less robust, with a 2024 review showing a 30-60% risk reduction [2]. If you're an adult starting antibiotics, a high-dose probiotic containing L. rhamnosus or S. boulardii is a reasonable option, but discuss it with your doctor first.
Caveats: Probiotics should be used cautiously in severely immunocompromised individuals or those with central venous catheters, as rare serious infections have been reported [3]. Also, the quality of many studies is moderate, and results vary by probiotic formulation. The 2023 overview noted that many systematic reviews have methodological flaws, so conclusions should be treated with caution [5]. Finally, probiotics do not replace standard medical care — if you develop severe diarrhea, especially with fever or blood, seek medical attention.
Sources used in this answer
Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children
A multispecies probiotic did not reduce the risk of AAD in children by the strictest definition (RR 0.81, 95% CI 0.49-1.33), but it reduced overall diarrhea risk by 35% (RR 0.65, 95% CI 0.44-0.94).
Efficacy of Probiotics in Preventing Antibiotic-Associated Diarrhea in Outpatients
A systematic review of 5 studies in outpatients found probiotic supplementation reduced AAD incidence by 30% to 60% compared to placebo.
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
A Cochrane review of 33 trials (6,352 children) found probiotics reduced AAD from 19% to 8% (RR 0.45, 95% CI 0.36-0.56); high-dose probiotics (≥5 billion CFUs/day) were more effective, reducing AAD from 23% to 8% (NNTB 6).
From Chaos to Clarity? The Quest for Effective Probiotics in Antibiotic-Associated Diarrhea
A randomized trial found a proprietary probiotic mixture reduced AAD incidence by 16%, but progress depends on transparency in strain selection and mechanistic studies.
Overview of systematic reviews of probiotics in the prevention and treatment of antibiotic-associated diarrhea in children
An overview of 20 systematic reviews concluded high-dose probiotics (5-40 billion CFUs/day) effectively prevent AAD in children, but evidence is strongest for Lacticaseibacillus rhamnosus and Saccharomyces boulardii.
